Traws Pharma, Inc. (TRAW)

Traws Pharma Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	21.34	20.82	38.76	55.07	19.03
Cash & Short-Term Investments	21.34	20.82	38.76	55.07	19.03
Cash Growth	2.48%	-46.28%	-29.62%	189.46%	-16.29%
Accounts Receivable	-	0.02	0.03	0.03	0.04
Other Receivables	1.77	-	-	-	-
Receivables	1.77	0.02	0.03	0.03	0.04
Inventory	-	0.19	0.1	0.03	0.09
Prepaid Expenses	1.85	0.17	0.19	0.25	0.26
Other Current Assets	-	1.46	0.27	0.05	0.37
Total Current Assets	24.95	22.66	39.35	55.43	19.78
Property, Plant & Equipment	0.01	0.02	0.02	0.04	0.05
Other Long-Term Assets	0	0	0	0.01	0.15
Total Assets	24.96	22.68	39.37	55.48	19.99
Accounts Payable	8.19	5.62	3.86	2.76	4.83
Accrued Expenses	3.12	3.38	3.96	3.13	4.96
Current Unearned Revenue	0.23	0.23	0.23	0.23	0.23
Total Current Liabilities	11.53	9.22	8.05	6.12	10.02
Long-Term Unearned Revenue	2.57	2.79	3.02	3.24	3.47
Other Long-Term Liabilities	42.49	-	-	-	0.32
Total Liabilities	56.59	12.01	11.06	9.36	13.81
Common Stock	0.04	0.21	0.21	0.21	0.12
Additional Paid-In Capital	617.53	493.12	491.82	490.64	434.59
Retained Earnings	-649.15	-482.63	-463.68	-444.72	-428.56
Comprehensive Income & Other	-0.04	-0.02	-0.03	-0.01	0.01
Total Common Equity	-31.63	10.67	28.31	46.12	6.18
Shareholders' Equity	-31.63	10.67	28.31	46.12	6.18
Total Liabilities & Equity	24.96	22.68	39.37	55.48	19.99
Net Cash (Debt)	21.34	20.82	38.76	55.07	19.03
Net Cash Growth	2.48%	-46.28%	-29.62%	189.46%	-16.29%
Net Cash Per Share	13.74	24.80	46.34	81.79	40.99
Filing Date Shares Outstanding	0.84	0.84	0.84	0.84	0.63
Total Common Shares Outstanding	0.84	0.84	0.84	0.84	0.5
Working Capital	13.42	13.44	31.3	49.32	9.76
Book Value Per Share	-37.64	12.70	33.82	55.18	12.45
Tangible Book Value	-31.63	10.67	28.31	46.12	6.18
Tangible Book Value Per Share	-37.64	12.70	33.82	55.18	12.45
Machinery	-	0.08	0.07	0.07	0.07

Updated Nov 14, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q